Literature DB >> 9620769

The forkhead transcription factor gene FKHL7 is responsible for glaucoma phenotypes which map to 6p25.

D Y Nishimura1, R E Swiderski, W L Alward, C C Searby, S R Patil, S R Bennet, A B Kanis, J M Gastier, E M Stone, V C Sheffield.   

Abstract

A number of different eye disorders with the presence of early-onset glaucoma as a component of the phenotype have been mapped to human chromosome 6p25. These disorders have been postulated to be either allelic to each other or associated with a cluster of tightly linked genes. We have identified two primary congenital glaucoma (PCG) patients with chromosomal anomalies involving 6p25. In order to identify a gene involved in PCG, the chromosomal breakpoints in a patient with a balanced translocation between 6p25 and 13q22 were cloned. Cloning of the 6p25 breakpoint led to the identification of two candidate genes based on proximity to the breakpoint. One of these, FKHL7, encoding a forkhead transcription factor, is in close proximity to the breakpoint in the balanced translocation patient and is deleted in a second PCG patient with partial 6p monosomy. Furthermore, FKHL7 was found to harbour mutations in patients diagnosed with Rieger anomaly (RA), Axenfeld anomaly (AA) and iris hypoplasia (IH). This study demonstrates that mutations in FKHL7 cause a spectrum of glaucoma phenotypes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9620769     DOI: 10.1038/493

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  125 in total

1.  Analyses of the effects that disease-causing missense mutations have on the structure and function of the winged-helix protein FOXC1.

Authors:  R A Saleem; S Banerjee-Basu; F B Berry; A D Baxevanis; M A Walter
Journal:  Am J Hum Genet       Date:  2001-03       Impact factor: 11.025

2.  Chromosomal translocation in a family with ocular anomalies: indications for karyotype analysis.

Authors:  R V Jamieson; L Gaunt; D Donnai; G C M Black; B Kerr; O Stecko; G C M Black
Journal:  Br J Ophthalmol       Date:  2003-05       Impact factor: 4.638

3.  Gene content and function of the ancestral chromosome fusion site in human chromosome 2q13-2q14.1 and paralogous regions.

Authors:  Yuxin Fan; Tera Newman; Elena Linardopoulou; Barbara J Trask
Journal:  Genome Res       Date:  2002-11       Impact factor: 9.043

4.  FOXD1 Duplication Causes Branchial Defects and Interacts with the TFAP2A Gene Implicated in the Branchio-Oculo-Facial Syndrome in Causing Eye Effects in Zebrafish.

Authors:  I Balikova; K Devriendt; J-P Fryns; J R Vermeesch
Journal:  Mol Syndromol       Date:  2011-05-18

5.  A forkhead gene, FoxE3, is essential for lens epithelial proliferation and closure of the lens vesicle.

Authors:  A Blixt; M Mahlapuu; M Aitola; M Pelto-Huikko; S Enerbäck; P Carlsson
Journal:  Genes Dev       Date:  2000-01-15       Impact factor: 11.361

6.  Essential structural and functional determinants within the forkhead domain of FOXC1.

Authors:  R A Saleem; S Banerjee-Basu; T C Murphy; A Baxevanis; M A Walter
Journal:  Nucleic Acids Res       Date:  2004-08-06       Impact factor: 16.971

Review 7.  Glaucoma genetics.

Authors:  Pratap Challa
Journal:  Int Ophthalmol Clin       Date:  2008

Review 8.  Role of microRNAs in the trabecular meshwork.

Authors:  Pedro Gonzalez; Guorng Li; Jianming Qiu; Jing Wu; Coralia Luna
Journal:  J Ocul Pharmacol Ther       Date:  2014-01-02       Impact factor: 2.671

9.  Cortical dysplasia and skull defects in mice with a Foxc1 allele reveal the role of meningeal differentiation in regulating cortical development.

Authors:  Konstantinos Zarbalis; Julie A Siegenthaler; Youngshik Choe; Scott R May; Andrew S Peterson; Samuel J Pleasure
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-21       Impact factor: 11.205

10.  Targeted Disruption of the Myocilin Gene (Myoc) Suggests that Human Glaucoma-Causing Mutations Are Gain of Function.

Authors:  B S Kim; O V Savinova; M V Reedy; J Martin; Y Lun; L Gan; R S Smith; S I Tomarev; S W John; R L Johnson
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.